Trastuzumab is an antineoplastic agent and is a recombinant humanized IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2).
It is a HER2/neu receptor antagonist indicated for:
Trastuzumab for injection 440mg
Lyophilized Powder for concentrate for solution for Intravenous Infusion.
For IV infusion after reconstitution with 20 mL Bacteriostatic Water for Injection (diluent) provided with the pack.
Copyright ©2025. All Rights Reserved
